ARTICLE | Clinical News

Sanvar IR vapreotide: Phase III start

June 5, 2006 7:00 AM UTC

Debiopharm will start this month a single-arm, open-label, U.S. Phase III trial in 85 patients. Data are expected by year end or early 2007. The new trial was requested by FDA as part of an approvable...